Startups
AmunBio is a development stage biotechnology company focused on oncolytic virus therapy for cancer.
Overview
Location
United States, Washington, Seattle
Employees
11-50
Founded date
2020
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 13, 2021 | AmunBio and NorthShore University HealthSystem to Advance Cancer Immunotherapy with Next Generation Engineered Oncolytic Viruses | The collaboration between AmunBio and NorthShore University HealthSystem’s Research Institute helps us to address the challenges that have prevented previous endeavors from delivering on the full potential of immunotherapeutic oncolytic vir... |
Reviews 0
FAQ about AmunBio, Inc
When was AmunBio, Inc founded?
AmunBio, Inc was founded in 2020.
What has the press written about AmunBio, Inc?
Parsers VC has collected 2 articles mentioning AmunBio, Inc, among them “AmunBio and NorthShore University HealthSystem to Advance Cancer Immunotherapy with Next Generation Engineered Oncolytic Viruses” (Apr 13, 2021).
Is AmunBio, Inc still active?
Yes, AmunBio, Inc is active; its latest activity on Parsers VC dates from Nov 22, 2022.